Clinical scenario
You are working in the South ED and pick up a 62-year-old man with hypertension who presents with a sudden-onset, worst headache of his life. GCS 10 (E3V2M5), BP 210/118, HR 62. CT head shows diffuse subarachnoid hemorrhage.
He is protecting his airway for now, but his mental status is declining. You need to intubate, and then transfer him.
This is not a crashing airway. It is a semi-elective neurocritical care intubation in which every hemodynamic swing can cause secondary brain injury. Because he must be transferred afterward, every decision, from positioning to sedation to ventilator settings, has to be made to survive the ride.
Why is this intubation different?
During laryngoscopy, the reflex sympathetic surge raises heart rate (by up to 30 bpm) and MAP (by up to 25–50 mmHg).
In a healthy brain, autoregulation buffers these swings. In acute intracranial hemorrhage or high-grade SAH, autoregulation is impaired, so every BP spike reaches the injured brain directly, risking hematoma expansion, rebleeding, or herniation.
The goal: a gentle intubation with minimal hemodynamic disturbance.
Which patients?
This approach is for the patient who needs a tube but is not in arrest or actively coding:
Intracerebral hemorrhage with a declining GCS
High-grade subarachnoid hemorrhage
Large-territory ischemic stroke with cerebral edema
These patients give you time to optimize. It does not apply to the crashing TBI patient in the trauma bay, who gets a standard RSI.
Pre-intubation setup
Position: head of bed at 30–45° before, during, and after intubation, and throughout transport. This improves cerebral venous drainage and lowers ICP. Confirm stretcher positioning with the transport team before departure.
ETCO₂ monitoring: capnography running before and after intubation.
Arterial line: place it before induction. Beat-to-beat BP monitoring is essential.
Blade: use a hyperangulated video laryngoscope. Less force on the airway means less sympathetic stimulation and a smaller ICP spike.
Pretreatment
Blood pressure control: nicardipine
Start a nicardipine infusion (5–15 mg/h) before induction to control hypertension.
Preferred because it is fast-acting, easily titratable, does not raise ICP, and reaches target BP faster than labetalol.
Continue it after intubation and during transport.
Sympatholysis: fentanyl
Fentanyl blunts the sympathetic response to laryngoscopy. The standard pretreatment dose is 1–3 mcg/kg IV about 3 minutes before induction.
Higher doses (5 mcg/kg) blunt the response more but increase the risk of apnea, hypotension, and chest wall rigidity. Monitor closely, with ETCO₂ in place before intubation.
Practical approach: give 50–100 mcg IV at a time, reassess ETCO₂ and hemodynamics, and repeat as needed. This transitions easily into a continuous infusion for post-intubation sedation.
Esmolol, if needed
Esmolol 1.5–2 mg/kg IV immediately before laryngoscopy is well supported for blunting the sympathetic response if hypertension persists despite the above.
Lidocaine: IV versus topical
IV lidocaine (1.5 mg/kg) has traditionally been used to blunt the ICP response, but no study shows improved patient-centered outcomes, and current consensus does not recommend routine IV lidocaine pretreatment.
Topical airway lidocaine may be more effective at suppressing the cough reflex and airway stimulation that drive the sympathetic surge. Consider it as an alternative.
Osmotherapy: hypertonic saline
Give 250 mL of 3% hypertonic saline before induction as prophylactic ICP-lowering therapy and a buffer against the transient ICP rise during laryngoscopy.
Hypertonic saline lowers ICP and supports cerebral perfusion pressure, unlike mannitol, which can cause hypotension through osmotic diuresis.
Induction
| Agent | Dose | Advantages | Limitations |
|---|---|---|---|
| Etomidate | 0.3 mg/kg IV | Most hemodynamically stable induction agent | No reduction in ICP or cerebral metabolic demand |
| Ketamine | 1.5–2 mg/kg IV | Acceptable in neurocritical care; preserves hemodynamics; current evidence does not show clinically significant ICP increase | Mild sympathomimetic effects may raise HR and BP |
| Propofol | 2 mg/kg IV | Reduces ICP, cerebral blood flow, and cerebral metabolic rate; ideal if a propofol infusion is planned for sedation | Can cause significant hypotension; requires close monitoring |
| Ketofol | Ketamine 25% + propofol 75% | Theoretical hemodynamic neutrality | No clinical evidence |
The ideal induction agent is the one most likely to achieve the hemodynamic goals that minimize secondary brain injury for the patient in front of you.
Paralytic
Rocuronium 1.2 mg/kg is preferred over succinylcholine, whose fasciculations can transiently raise ICP.
Document a full neurologic exam before giving the paralytic whenever possible. If you cannot, sugammadex can rapidly reverse rocuronium to allow an accurate neurologic assessment.
Post-intubation ventilation
Target ETCO₂ of about 35 mmHg (PaCO₂ 35–40 mmHg). Hypercapnia increases cerebral blood flow and ICP; excessive hypocapnia reduces cerebral blood flow and risks ischemia.
ETCO₂ above 35 mmHg → increase the respiratory rate.
ETCO₂ below 35 mmHg → obtain a blood gas for the true PaCO₂ before making major ventilator changes.
Reserve hyperventilation for impending herniation.
Oxygenation
Unless there is a concurrent respiratory process (neurogenic pulmonary edema, ARDS, pneumonia, atelectasis), these patients need minimal PEEP or FiO₂ to keep SpO₂ > 94%.
Avoid hyperoxia. Target PaO₂ 80–100 mmHg and wean FiO₂. Do not leave patients on 100% FiO₂ out of habit.
Do not withhold oxygen when it is needed. If the patient needs more FiO₂ or PEEP to keep SpO₂ > 94%, give it: hypoxia is more harmful than hyperoxia.
Special caution: ischemic stroke and basilar occlusion
Be very cautious about lowering BP.
Basilar artery occlusion: intraprocedural MAP < 80 mmHg is associated with worse outcomes. Target MAP 80–110 mmHg.
Any ischemic stroke whose symptoms worsen as BP falls: the penumbra depends on pressure-driven collateral flow, and autoregulation there is impaired. Dropping the BP can turn salvageable penumbra into completed infarct.
The 2026 AHA/ASA guideline recommends individualized BP management in acute ischemic stroke with severe hypertension, with an initial reduction of no more than 15%, and cautions against aggressive lowering without a specific indication (thrombolysis, EVT, aortic dissection).
Key takeaways
1. This is not a crashing airway. It is a semi-elective neurocritical care intubation. Take the time to optimize physiology first.
2. Minimize secondary brain injury: blunt the sympathetic response, and avoid hypoxia, hypotension, hypercapnia, and unnecessary ICP rises.
3. Keep the head of bed at 30–45° through intubation and transport, target ETCO₂ of about 35 mmHg, avoid hyperoxia, and communicate transport goals clearly.
References
1. Ko CL, Celmins L. Pharmacology for rapid sequence intubation (RSI) airway management in trauma patients. JOMI. 2024.
2. Chung KS, Sinatra RS, Halevy JD, Paige D, Silverman DG. A comparison of fentanyl, esmolol, and their combination for blunting the haemodynamic responses during rapid-sequence induction. Can J Anaesth. 1992;39(8):774–779.
3. Maissan IM, Hollestelle RV, Rijs K, et al. Intravenous lidocaine attenuates distention of the optical nerve sheath, a correlate of intracranial pressure, during endotracheal intubation. Minerva Anestesiol. 2023;89(3):182–189.
4. Bucher J, Koyfman A. Intubation of the neurologically injured patient. 2015;49(6):966–975.
5. Schrag M, Kirshner H. Management of intracerebral hemorrhage: JACC focus seminar. J Am Coll Cardiol. 2020;75(15):1819–1831.
6. Ona DID, Punzalan FE, Oliva RV, et al. Executive summary of the 2024 Philippine clinical practice guidelines on the diagnosis and management of acute severe blood pressure elevation. J Clin Hypertens (Greenwich). 2026.
7. Zampieri FG, Schmidt RC, Besen BAMP, et al. Induction agents for emergency tracheal intubation in critically ill adults: a systematic review and network meta-analysis. 2026;30(1):215.
8. Acquisto NM, Mosier JM, Bittner EA, et al. SCCM clinical practice guidelines for rapid sequence intubation in the critically ill adult patient. Crit Care Med. 2023;51(10):1411–1430.
9. Smischney NJ, Nicholson WT, Brown DR, et al. Ketamine/propofol admixture vs etomidate for intubation in the critically ill: KEEP PACE randomized clinical trial. 2019;87(4):883–891.
10. Dao AQ, Mohapatra S, Kuza C, Moon TS. Traumatic brain injury and RSI: is rocuronium or succinylcholine preferred? Curr Opin Anaesthesiol. 2023;36(2):234–241.
11. Manley GT, Albert GW, Brophy GM, et al. Best practices in the management of traumatic brain injury. American College of Surgeons. 2024.
12. Carney N, Totten AM, O'Reilly C, et al. Guidelines for the management of severe TBI, 4th edition. Brain Trauma Foundation. 2016.
13. Romero-Garcia N, Robba C, Monleón B, et al. Neurological outcomes and mortality following hyperoxemia in adult patients with acute brain injury: an updated meta-analysis and meta-regression. Crit Care. 2025;29(1):163.
14. Rezoagli E, Petrosino M, Rebora P, et al. High arterial oxygen levels and supplemental oxygen administration in traumatic brain injury: insights from CENTER-TBI and OzENTER-TBI. Intensive Care Med. 2022;48(8):1105–1115.
15. Lalla LT, Czorlich P, Fischer M, et al. Dose-dependent association of hyperoxia and decreased favorable outcomes in mechanically ventilated patients with traumatic brain injury: a retrospective cohort study. Eur J Trauma Emerg Surg. 2025.
16. Prabhakaran S, Gonzalez NR, Zachrison KS, et al. 2026 Guideline for the early management of patients with acute ischemic stroke: a guideline from the American Heart Association/American Stroke Association. Stroke. 2026;57(2):e48–e200.
17. Luo C, Nguyen TN, Li R, et al. Association between collateral status, blood pressure during thrombectomy, and clinical outcomes in patients with basilar artery occlusion. 2025;104(9):e210234.
